Hemostats Market Set to Reach US$ 4.71 Billion by 2031 with 7.1% CAGR as Surgical Innovation Accelerates

United States of America – November 19, 2025 – According to The Insight Partners, the hemostats market size is projected to reach US$ 4.71 billion by 2031 from US$ 2.72 billion in 2023. The market is expected to register a CAGR of 7.1% during 2023–2031. The landscape of surgical care is evolving rapidly. Hemostats—a cornerstone for effective bleeding control during procedures—are at the forefront of this evolution, empowering doctors and improving patient outcomes around the globe. Bolstered by new product launches, accelerating healthcare investments, and the growing prevalence of complex surgeries, the market is heading into 2031 with renewed promise and innovation.​

Check valuable insights in the Hemostats Market report. You can easily get a sample PDF of the report - https://www.theinsightpartners.com/sample/TIPHE100001419/

Empowering Healthcare

From trauma centers to precision-driven cosmetic clinics, hemostats are saving lives by helping to minimize complications, accelerate operating times, and support quick recoveries for patients of all backgrounds. Market participants—including leading names such as Johnson & Johnson (Ethicon LLC), BD, Baxter, B. Braun Melsungen AG, Pfizer, GELITA MEDICAL, Integra LifeSciences, Z-Medica, LLC, and Biom—are driving improvements in product efficacy and broader accessibility each year.​

Championing Innovation

Recent product launches further elevate the market. Baxter introduced its HEMOPATCH Sealing Hemostat, a collagen-based pad designed for superior sealing and ease of use in Europe in April 2024. Johnson & Johnson’s Ethizia solution continues to show clinical promise for achieving hemostasis even in difficult bleeding scenarios, showcasing the sector’s commitment to meaningful surgical solutions.​

Regional Growth and Analysis

The Asia Pacific region stands as the fastest-growing market due to increasing surgical volumes, scaling healthcare infrastructure, and a rapidly expanding middle class—particularly in China, India, and Japan. North America leads global revenue, supported by high surgical rates and extensive adoption of innovative hemostatic agents, while Europe benefits from aging populations and growing demand for minimally invasive procedures.​

Latin America and the Middle East & Africa are emerging vital players, witnessing improvements in healthcare spending and a surge in surgical activity. Investment in medical tourism and public-private collaborations is fostering awareness and adoption of advanced hemostatic technologies in these regions.​

Market Segmentation (by Product)

• Thrombin-Based Hemostats: Preferred for high efficacy and rapid action in surgical settings, especially trauma and cardiac procedures.​
• Combination Hemostats: Fastest growth segment due to their dual-action effectiveness in complex surgeries (cardiac, orthopedic).​
• Gelatin-Based and Collagen-Based Hemostats: Emphasized for their absorbable qualities, supporting wound healing and recovery.​
• Oxidized Regenerated Cellulose-Based Hemostats: Widely adopted owing to predictable absorption profiles and ease of integration with current surgical protocols.​

Market Segmentation (by End User)

• Hospitals and Clinics: Dominate overall adoption due to growing volumes of surgical procedures, expanded access to advanced hemostatic agents, and favorable reimbursement frameworks.​
• Ambulatory Surgical Centers (ASCs): Rapid growth fueled by medical convenience, improved patient inflow, and rising acceptance of minimally invasive operations.​

Forecast & Trends by 2031

• Expanding utilization of hemostats in aesthetic, trauma, oncology, and reconstructive surgeries.​
• Steady introduction of novel formulations, improved storage, and emergency capabilities, especially powder hemostats.​
• Growing pressure to minimize product pricing and meet stringent regulatory criteria for broader global adoption.​
• Increasing educational outreach to surgeons, strategic alliances with local distributors, and localization of manufacturing in emerging regions.​
• Movement toward personalized surgical care, patient safety, and value-driven procurement strategies.​

Key Market Size, Share, and Forecast Insights (Excluding Numerical Data)

• The market expects accelerated growth from advanced surgical techniques and a steeper rise in hemostatic agents tailored to specific procedures by 2031.​
• North America will maintain its position as the leading market, followed by robust expansion in Asia Pacific.
• Hospitals and clinics remain the key end-user segment, but ambulatory surgical centers will show an impressive increase in adoption rates.
• Thrombin-based and combination hemostats products are expected to capture substantial market share, propelled by rising demand for efficacy and rapid action.
• Technological breakthroughs, such as collagen-based absorption pads and dual-action agents, are set to expand market reach even further.

Get Premium Research Report of Hemostats Market Size and Growth Report by 2031 at: https://www.theinsightpartners.com/buy/TIPHE100001419

About the Hemostats Market

The hemostats market is a rapidly evolving segment of the global healthcare landscape, delivering vital solutions for bleeding control and recovery for patients undergoing surgical interventions. Supported by leading healthcare manufacturers and a robust research pipeline, the market is transforming patient care across regions with commitment to safety, innovation, and accessibility.​

Related Reports

• Flowable Hemostats Market Growth and Analysis by 2031
• Absorbable Hemostat Market Drivers, Opportunities, Trends, and Forecasts by 2031
• Active Hemostatic Agents Market Growth, Key Players Analysis, and Forecast till 2031
• Hemostasis and Tissue Sealing Agents Market Report 2031
• Thrombin Market Growth Opportunities and Forecast by 2031

About The Insight Partners

The Insight Partners is among the leading market research and consulting firms in the world. We take pride in delivering exclusive reports along with sophisticated strategic and tactical insights into the industry. Reports are generated through a combination of primary and secondary research, solely aimed at giving our clientele a knowledge-based insight into the market and domain. This is done to assist clients in making wiser business decisions. A holistic perspective in every study undertaken forms an integral part of our research methodology and makes the report unique and reliable.

Contact Us:

If you have any queries about this report or if you would like further information, please get in touch with us:

Contact Person: Ankit Mathur

E-mail: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876

Also Available in: 日本 | 한국어 | Français | لعربية< | 中文 | Italiano | Español | Deutsch